Mr. Cooper Group Inc. (COOP)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,350	6,143	4,289	2,832	3,126	2,819
Market Cap Growth	81.60%	43.23%	51.45%	-9.41%	10.88%	147.41%
Enterprise Value	22,699	15,604	11,433	9,599	15,214	18,544
Last Close Price	177.35	96.01	65.12	40.13	41.61	31.03
PE Ratio	20.26	9.18	8.58	3.07	2.20	9.34
Forward PE	12.77	7.61	8.35	9.84	8.10	4.61
PS Ratio	5.05	2.76	2.39	1.15	0.94	1.05
PB Ratio	2.23	1.28	1.00	0.70	0.93	1.13
P/FCF Ratio	-	-	5.08	0.76	1.21	10.29
P/OCF Ratio	-	-	4.79	0.75	1.19	8.52
EV/Sales Ratio	10.11	7.01	6.37	3.90	4.59	6.90
EV/EBITDA Ratio	11.81	8.16	8.77	4.79	8.88	18.92
EV/EBIT Ratio	27.38	16.51	17.30	8.07	9.19	20.45
EV/FCF Ratio	-	-	13.55	2.56	5.87	67.68
Debt / Equity Ratio	2.39	2.62	1.99	1.86	2.76	5.83
Debt / EBITDA Ratio	6.22	6.48	6.44	3.71	5.34	14.44
Debt / FCF Ratio	-	-	10.08	2.01	3.58	53.28
Asset Turnover	0.13	0.13	0.13	0.18	0.17	0.13
Quick Ratio	0.28	0.61	0.71	0.33	0.76	0.11
Current Ratio	1.91	4.41	3.89	2.41	5.42	1.70
Return on Equity (ROE)	11.76%	14.71%	11.99%	24.87%	49.94%	13.05%
Return on Assets (ROA)	3.02%	3.56%	3.06%	5.51%	5.39%	2.67%
Return on Capital (ROIC)	3.26%	3.91%	3.39%	6.14%	6.96%	3.47%
Return on Capital Employed (ROCE)	5.40%	5.40%	5.00%	10.90%	13.10%	7.20%
Earnings Yield	5.02%	10.89%	11.66%	32.59%	46.52%	10.82%
FCF Yield	-12.53%	-33.75%	19.68%	132.43%	82.89%	9.72%
Buyback Yield / Dilution	2.30%	4.18%	7.14%	13.97%	9.19%	-2.55%

Updated Jul 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q